Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-461262
Filing Date
2012-11-09
Accepted
2012-11-08 21:29:17
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d406677d10q.htm 10-Q 706167
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) d406677dex31a.htm EX-31.(A) 6256
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) d406677dex31b.htm EX-31.(B) 6341
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d406677dex32a.htm EX-32.(A) 3611
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d406677dex32b.htm EX-32.(B) 3738
  Complete submission text file 0001193125-12-461262.txt   5123866

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dusa-20120930.xml EX-101.INS 845499
8 XBRL TAXONOMY EXTENSION SCHEMA dusa-20120930.xsd EX-101.SCH 46490
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dusa-20120930_cal.xml EX-101.CAL 71310
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dusa-20120930_def.xml EX-101.DEF 242860
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dusa-20120930_lab.xml EX-101.LAB 364155
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dusa-20120930_pre.xml EX-101.PRE 287565
Mailing Address 25 UPTON DRIVE WILMINGTON MA 01887
Business Address 25 UPTON DRIVE WILMINGTON MA 01887 9786577500
DUSA PHARMACEUTICALS INC (Filer) CIK: 0000879993 (see all company filings)

EIN.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31533 | Film No.: 121191504
SIC: 2834 Pharmaceutical Preparations